KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Asset Writedowns and Impairment (2016 - 2017)

Encompass Health (EHC) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $15.4 million as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Asset Writedowns and Impairment rose 41.28% year-over-year to $15.4 million, compared with a TTM value of $56.8 million through Jun 2016, up 62.29%, and an annual FY2017 reading of $52.4 million, changed N/A over the prior year.
  • Asset Writedowns and Impairment was $15.4 million for Q2 2016 at Encompass Health, down from $16.5 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $16.5 million in Q1 2016 and bottomed at $6.3 million in Q1 2012.
  • Average Asset Writedowns and Impairment over 5 years is $9.9 million, with a median of $8.2 million recorded in 2014.
  • The sharpest move saw Asset Writedowns and Impairment increased 1.35% in 2014, then soared 112.12% in 2015.
  • Year by year, Asset Writedowns and Impairment stood at $6.3 million in 2012, then increased by 11.11% to $7.0 million in 2013, then dropped by 5.71% to $6.6 million in 2014, then skyrocketed by 112.12% to $14.0 million in 2015, then increased by 10.0% to $15.4 million in 2016.
  • Business Quant data shows Asset Writedowns and Impairment for EHC at $15.4 million in Q2 2016, $16.5 million in Q1 2016, and $14.0 million in Q4 2015.